loading

Theravance Biopharma Inc Aktie (TBPH) Neueste Nachrichten

pulisher
Dec 19, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 21,372 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

Dec 19, 2024
pulisher
Dec 19, 2024

Wellington Management Group LLP Sells 159,258 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat

Dec 19, 2024
pulisher
Dec 17, 2024

When (TBPH) Moves Investors should Listen - Stock Traders Daily

Dec 17, 2024
pulisher
Dec 17, 2024

Theravance Biopharma to Meet Investors at J.P. Morgan Healthcare Conference 2025 - StockTitan

Dec 17, 2024
pulisher
Dec 13, 2024

Theravance Bio (TBPH) Up 3.7% Since Last Earnings Report: Can It Continue? - MSN

Dec 13, 2024
pulisher
Dec 11, 2024

The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable - Yahoo Finance

Dec 11, 2024
pulisher
Dec 10, 2024

Diabetic Gastroparesis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Theravance Biopharma, Eli Lilly and Company, Processa Pharmaceuticals, PTC Therapeutics - The Globe and Mail

Dec 10, 2024
pulisher
Dec 09, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Dec 09, 2024
pulisher
Dec 07, 2024

What is Zacks Research's Estimate for TBPH FY2024 Earnings? - MarketBeat

Dec 07, 2024
pulisher
Dec 07, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Acquired by BNP Paribas Financial Markets - MarketBeat

Dec 07, 2024
pulisher
Dec 06, 2024

(TBPH) Trading Advice - Stock Traders Daily

Dec 06, 2024
pulisher
Dec 04, 2024

Theravance Biopharma (STU:0TB) Shares Outstanding (EOP) : 49.17 Mil (As of Sep. 2024) - GuruFocus.com

Dec 04, 2024
pulisher
Nov 30, 2024

105,609 Shares in Theravance Biopharma, Inc. (NASDAQ:TBPH) Bought by Algert Global LLC - MarketBeat

Nov 30, 2024
pulisher
Nov 26, 2024

Trading (TBPH) With Integrated Risk Controls - Stock Traders Daily

Nov 26, 2024
pulisher
Nov 21, 2024

Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y - MSN

Nov 21, 2024
pulisher
Nov 20, 2024

Multiple System Atrophy Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma - The Globe and Mail

Nov 20, 2024
pulisher
Nov 20, 2024

Theravance Biopharma to Participate in an Upcoming Investor Conference - Citizentribune

Nov 20, 2024
pulisher
Nov 20, 2024

Theravance Biopharma to Present at Evercore HealthCONx Conference | TBPH Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 20, 2024

Baupost's top Q3 trades include Jazz exit, new Dollar General stake - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 19, 2024
pulisher
Nov 15, 2024

(TBPH) Investment Report - Stock Traders Daily

Nov 15, 2024
pulisher
Nov 15, 2024

Theravance Biopharma Inc (TBPH) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

Madison Avenue Partners, LP Expands Stake in Theravance Biopharm - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Theravance Biopharma Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Analysts Set Theravance Biopharma, Inc. (NASDAQ:TBPH) PT at $13.75 - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Theravance Biopharma SVP Rhonda Farnum sells $36,000 in shares - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

Theravance Biopharma SVP Rhonda Farnum sells $36,000 in shares By Investing.com - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Earnings call: Theravance Biopharma reports growth in Q3 2024 - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Theravance Biopharma (NASDAQ:TBPH) Stock Price Crosses Above Fifty Day Moving AverageTime to Sell? - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Initiatives - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

Theravance Biopharma’s Third Quarter 2024 Financial Insights - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Theravance Biopharma Q3 2024 Earnings: Revenue Surpasses Estimat - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Theravance Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

With Theravance Biopharma, Inc. (NASDAQ:TBPH) It Looks Like You'll Get What You Pay For - Simply Wall St

Nov 12, 2024
pulisher
Nov 11, 2024

What To Expect From Theravance Biopharma Inc (TBPH) Q3 2024 Earnings - GuruFocus.com

Nov 11, 2024
pulisher
Nov 11, 2024

Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance - Yahoo Finance

Nov 11, 2024
pulisher
Nov 10, 2024

Theravance Biopharma (TBPH) Scheduled to Post Earnings on Tuesday - Defense World

Nov 10, 2024
pulisher
Nov 08, 2024

5 Small Drug Stocks to Buy as Trump Gets Re-Elected - Yahoo Finance

Nov 08, 2024
pulisher
Nov 05, 2024

Theravance Biopharma (TBPH) Set to Announce Quarterly Earnings on Tuesday - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Theravance Biophar - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

(TBPH) Proactive Strategies - Stock Traders Daily

Nov 04, 2024
pulisher
Oct 26, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Sold by SG Americas Securities LLC - MarketBeat

Oct 26, 2024
pulisher
Oct 24, 2024

Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024 - StockTitan

Oct 24, 2024
pulisher
Oct 23, 2024

Q3 EPS Estimate for Theravance Biopharma Boosted by Analyst - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Brokerages Set Theravance Biopharma, Inc. (NASDAQ:TBPH) PT at $13.75 - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

What is Zacks Research's Estimate for TBPH Q4 Earnings? - MarketBeat

Oct 22, 2024
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):